Table of Contents

1 Industry Overview

• 1.1 Liposomes Drug Delivery Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Liposomes Drug Delivery
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Liposomes Drug Delivery Market by Type

• 3.1 By Type
  • 3.1.1 Liposomal doxorubicin
  • 3.1.2 Liposomal Amphoteracin B
  • 3.1.3 Liposomal Paclitaxel
  • 3.1.4 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Liposomes Drug Delivery Johnson & Johnson (Company Profile, Sales Data etc.)

• 4.2 Gilead Sciences (Company Profile, Sales Data etc.)
• 4.3 Luye Pharma (Company Profile, Sales Data etc.)
• 4.4 Sun Pharmaceutical (Company Profile, Sales Data etc.)
• 4.5 Pacira (Company Profile, Sales Data etc.)
• 4.6 Fudan-Zhangjiang (Company Profile, Sales Data etc.)
• 4.7 Sigma-Tau Group (Company Profile, Sales Data etc.)
• 4.8 Teva Pharmaceutical (Company Profile, Sales Data etc.)
• 4.9 CSPC (Company Profile, Sales Data etc.)
• 4.10 Novartis (Company Profile, Sales Data etc.)
• 4.11 Crucell (Company Profile, Sales Data etc.)
• 4.12 Celsion Corporation (Company Profile, Sales Data etc.)
• 4.13 Kingond Pharm (Company Profile, Sales Data etc.)
• 4.14 Shanghai New Asia (Company Profile, Sales Data etc.)
• 4.15 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Fungal Infection Therapy
  • 6.1.2 Demand in Cancer Therapy ( Tumor therapy)
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Liposomes Drug Delivery

Table Application Segment of Liposomes Drug Delivery

Table Global Liposomes Drug Delivery Market 2013-2024, by Application, in USD Million

Table Major Company List of Liposomal doxorubicin

Table Major Company List of Liposomal Amphoteracin B

Table Major Company List of Liposomal Paclitaxel

Table Major Company List of Others

Table Global Liposomes Drug Delivery Market 2013-2018, by Type, in USD Million

Table Global Liposomes Drug Delivery Market 2013-2018, by Type, in Volume

Table Global Liposomes Drug Delivery Market Forecast 2019-2024, by Type, in USD Million

Table Global Liposomes Drug Delivery Market Forecast 2019-2024, by Type, in Volume

Table Johnson & Johnson Overview List

Table Liposomes Drug Delivery Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Gilead Sciences Overview List

Table Liposomes Drug Delivery Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Luye Pharma Overview List

Table Liposomes Drug Delivery Business Operation of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sun Pharmaceutical Overview List

Table Liposomes Drug Delivery Business Operation of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pacira Overview List

Table Liposomes Drug Delivery Business Operation of Pacira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Fudan-Zhangjiang Overview List

Table Liposomes Drug Delivery Business Operation of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sigma-Tau Group Overview List

Table Liposomes Drug Delivery Business Operation of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Pharmaceutical Overview List

Table Liposomes Drug Delivery Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CSPC Overview List

Table Liposomes Drug Delivery Business Operation of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Liposomes Drug Delivery Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Crucell Overview List

Table Liposomes Drug Delivery Business Operation of Crucell (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celsion Corporation Overview List

Table Liposomes Drug Delivery Business Operation of Celsion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Kingond Pharm Overview List

Table Liposomes Drug Delivery Business Operation of Kingond Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shanghai New Asia Overview List

Table Liposomes Drug Delivery Business Operation of Shanghai New Asia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Spectrum Pharmaceuticals Overview List

Table Liposomes Drug Delivery Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Liposomes Drug Delivery Sales Revenue 2013-2018, by Company, in USD Million

Table Global Liposomes Drug Delivery Sales Revenue Share, by Company, in USD Million

Table Global Liposomes Drug Delivery Sales Volume 2013-2018, by Company, in Volume

Table Global Liposomes Drug Delivery Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Liposomes Drug Delivery Demand Forecast 2019-2024, by Application, in USD Million

Table Liposomes Drug Delivery Demand Forecast 2019-2024, by Application, in Volume

Table Liposomes Drug Delivery Production 2013-2018, by Region, in USD Million

Table Liposomes Drug Delivery Production 2013-2018, by Region, in Volume

Table Global Liposomes Drug Delivery Market 2013-2018, by Region, in USD Million

Table Global Liposomes Drug Delivery Market Share 2013-2018, by Region, in USD Million

Table Global Liposomes Drug Delivery Market 2013-2018, by Region, in Volume

Table Global Liposomes Drug Delivery Market Share 2013-2018, by Region, in Volume

Table North America Liposomes Drug Delivery Market Size 2013-2018, by Country, in USD Million

Table North America Liposomes Drug Delivery Market Size 2013-2018, by Country, in Volume

Table Europe Liposomes Drug Delivery Market Size 2013-2018, by Country, in USD Million

Table Europe Liposomes Drug Delivery Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Liposomes Drug Delivery Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Liposomes Drug Delivery Market Size 2013-2018, by Country, in Volume

Table South America Liposomes Drug Delivery Market Size 2013-2018, by Country, in USD Million

Table South America Liposomes Drug Delivery Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Liposomes Drug Delivery Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Liposomes Drug Delivery Market Size 2013-2018, by Country, in Volume

Table Liposomes Drug Delivery Market Forecast 2019-2024, by Region, in USD Million

Table Liposomes Drug Delivery Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Liposomes Drug Delivery Market Growth 2013-2018, by Type, in USD Million

Figure Global Liposomes Drug Delivery Market Growth 2013-2018, by Type, in Volume

Figure North America Liposomes Drug Delivery Market Concentration, in 2018

Figure Europe Liposomes Drug Delivery Market Market Concentration, in 2018

Figure Asia-Pacific Liposomes Drug Delivery MMarket Concentration, in 2018

Figure South America Liposomes Drug Delivery Market Concentration, in 2018

Figure Middle East & Africa Liposomes Drug Delivery Market Concentration, in 2018

Figure Liposomes Drug Delivery Demand in Fungal Infection Therapy, 2013-2018, in USD Million

Figure Liposomes Drug Delivery Demand in Fungal Infection Therapy, 2013-2018, in Volume

Figure Liposomes Drug Delivery Demand in Cancer Therapy ( Tumor therapy), 2013-2018, in USD Million

Figure Liposomes Drug Delivery Demand in Cancer Therapy ( Tumor therapy), 2013-2018, in Volume

Figure Liposomes Drug Delivery Demand in Others, 2013-2018, in USD Million

Figure Liposomes Drug Delivery Demand in Others, 2013-2018, in Volume

Figure North America Liposomes Drug Delivery Market Size and Growth 2013-2018, in USD Million

Figure North America Liposomes Drug Delivery Market Size and Growth 2013-2018, in Volume

Figure Europe Liposomes Drug Delivery Market Size and Growth 2013-2018, in USD Million

Figure Europe Liposomes Drug Delivery Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Liposomes Drug Delivery Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Liposomes Drug Delivery Market Size and Growth 2013-2018, in Volume

Figure South America Liposomes Drug Delivery Market Size and Growth 2013-2018, in USD Million

Figure South America Liposomes Drug Delivery Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Liposomes Drug Delivery Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Liposomes Drug Delivery Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global Liposomes Drug Delivery market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Liposomes Drug Delivery by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Liposomal doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Johnson & Johnson
Gilead Sciences
Luye Pharma
Sun Pharmaceutical
Pacira
Fudan-Zhangjiang
Sigma-Tau Group
Teva Pharmaceutical
CSPC
Novartis
Crucell
Celsion Corporation
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Fungal Infection Therapy
Cancer Therapy ( Tumor therapy)
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)